AbbVie Plans Specialty Drug Focus in Sales Growth Effort – Bloomberg
AbbVie Plans Specialty Drug Focus in Sales Growth EffortBloombergAbbVie also is developing daclizumab, a treatment for multiple sclerosis in the late stage of clinical trials that may reach the market by late 2015 or early 2016. Finally, the company ha…

